Kuwait City, Kuwait
Kuwait City, Kuwait

Time filter

Source Type

VISTA, Calif., May 23, 2017 /PRNewswire/ -- Leica Biosystems announced today that it has struck a key partnership with the Kuwait Ministry of Health, through its distributor, Technical Services Supplies Trading & Contracting Company, W.L.L. The Pathology Council of Kuwait will now adopt Leica Biosystems digital pathology as its standard of care. This initiative will create a nationwide pathology network, powered by Aperio ePathology Solutions, linking eight key hospitals and leveraging pathology expertise across the country. "With one of the most extensive digital pathology initiatives in the world, Kuwait is leading the charge to transform pathology and its critical role in healthcare," said Jerome Clavel, Vice President and General Manager for Leica Biosystems Pathology Imaging. "Our Aperio ePathology Solutions will enable rapid sharing and collaboration. This will reduce the need for pathologists to travel and increase patient access especially in remote locations." The Kuwait Cancer Control Center (KCCC) has been using Aperio ePathology since 2011, for both national and international slide sharing and collaboration. Building on their experience, the nationwide hub-and-spoke deployment of Aperio ePathology will enable efficient utilization of Kuwait's pathology expertise; providing pathologists with rapid access to slides and cases. "The full adoption of Aperio ePathology throughout Kuwait is a critical, technological advancement for the pathology workflow. It will make secondary reviews and collaboration easier, faster and more efficient. In the past, shipping of glass slides required 3 to 4 days by itself. Now, subspecialty expertise can be available to remote locations within 24 hours without sending any physical slides," said Dr. Abdullah Akbar, Consultant Pathologist, Head of the Laboratory Medicine Department, Sabah Hospital, and Head of the Histopathology Committee, Ministry of Health. "Digital Pathology will help to improve turnaround times, and therefore give patients faster results." *The clinical use claims described in the information provided have not been cleared or approved by the U.S. FDA nor are the products available in the United States. Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of "Advancing Cancer Diagnostics, Improving Lives" is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.


"With one of the most extensive digital pathology initiatives in the world, Kuwait is leading the charge to transform pathology and its critical role in healthcare," said Jerome Clavel, Vice President and General Manager for Leica Biosystems Pathology Imaging. "Our Aperio ePathology Solutions will enable rapid sharing and collaboration. This will reduce the need for pathologists to travel and increase patient access especially in remote locations." The Kuwait Cancer Control Center (KCCC) has been using Aperio ePathology since 2011, for both national and international slide sharing and collaboration. Building on their experience, the nationwide hub-and-spoke deployment of Aperio ePathology will enable efficient utilization of Kuwait's pathology expertise; providing pathologists with rapid access to slides and cases. "The full adoption of Aperio ePathology throughout Kuwait is a critical, technological advancement for the pathology workflow. It will make secondary reviews and collaboration easier, faster and more efficient. In the past, shipping of glass slides required 3 to 4 days by itself. Now, subspecialty expertise can be available to remote locations within 24 hours without sending any physical slides," said Dr. Abdullah Akbar, Consultant Pathologist, Head of the Laboratory Medicine Department, Sabah Hospital, and Head of the Histopathology Committee, Ministry of Health. "Digital Pathology will help to improve turnaround times, and therefore give patients faster results." *The clinical use claims described in the information provided have not been cleared or approved by the U.S. FDA nor are the products available in the United States. Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of "Advancing Cancer Diagnostics, Improving Lives" is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.


News Article | May 23, 2017
Site: www.prnewswire.co.uk

"With one of the most extensive digital pathology initiatives in the world, Kuwait is leading the charge to transform pathology and its critical role in healthcare," said Jerome Clavel, Vice President and General Manager for Leica Biosystems Pathology Imaging. "Our Aperio ePathology Solutions will enable rapid sharing and collaboration. This will reduce the need for pathologists to travel and increase patient access especially in remote locations." The Kuwait Cancer Control Center (KCCC) has been using Aperio ePathology since 2011, for both national and international slide sharing and collaboration. Building on their experience, the nationwide hub-and-spoke deployment of Aperio ePathology will enable efficient utilization of Kuwait's pathology expertise; providing pathologists with rapid access to slides and cases. "The full adoption of Aperio ePathology throughout Kuwait is a critical, technological advancement for the pathology workflow. It will make secondary reviews and collaboration easier, faster and more efficient. In the past, shipping of glass slides required 3 to 4 days by itself. Now, subspecialty expertise can be available to remote locations within 24 hours without sending any physical slides," said Dr. Abdullah Akbar, Consultant Pathologist, Head of the Laboratory Medicine Department, Sabah Hospital, and Head of the Histopathology Committee, Ministry of Health. "Digital Pathology will help to improve turnaround times, and therefore give patients faster results." *The clinical use claims described in the information provided have not been cleared or approved by the U.S. FDA nor are the products available in the United States. Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of "Advancing Cancer Diagnostics, Improving Lives" is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.


Bastaki J.M.,Sabah Hospital | Bastaki J.M.,Kuwait Cancer Control Center | Purgina B.M.,University of Ottawa | Dacic S.,University of Pittsburgh | Seethala R.R.,University of Pittsburgh
Head and Neck Pathology | Year: 2014

Signet ring cell (mucin producing) adenocarcinoma is a rare low grade salivary gland malignancy. While currently designated as an adenocarcinoma, myoepithelial differentiation has been implied in previously reported cases. We herein perform a survey of our cases of signet ring cell adenocarcinoma and review the literature in order to refine categorization of this rare tumor. Five cases were retrieved. One was reclassified as a mammary analogue secretory carcinoma, leaving four that fulfilled the criteria for signet ring cell adenocarcinoma: the presence of prominent signet ring or vacuolated cells arranged in islands, interconnecting strands, cords or sheets in a myxoid or hyaline stroma, or pools of mucin. An extensive panel of histochemical and immunohistochemical stains and fluorescence in situ hybridization (FISH) (modeled after common phenotypes and molecular alterations seen in signet ring and myoepithelial tumors at other sites) was performed. The male-to-female ratio was 3:1. The mean age was 56 years (range 18-81). Sites involved included buccal mucosa (2), soft palate (1) and deep parotid (1). Perineural and angiolymphatic invasion were present in three and two cases respectively. One patient was lost to follow up and the remainder were alive and without disease at time of last follow up (mean 38 months). All cases showed mucicarmine positive vacuolated/signet ring cells embedded in a myxoid stroma. Three cases showed at least focal p63 staining and two cases showed positivity for calponin. Membranous E-cadherin was retained in all cases. FISH was negative for ETV6, EWSR1, and ALK1 rearrangements in all four cases. Based on the current series and the previously reported cases, it is evident that signet ring adenocarcinomas have a dual secretory and myoepithelial phenotype and thus as a whole more appropriately designated as 'secretory myoepithelial carcinoma.' They behave in a fairly indolent fashion and do not share the major molecular alterations seen in other signet ring and myoepithelial tumor types. © 2014 Springer Science+Business Media New York.


Eshra A.,Sabah Hospital
The Gulf journal of oncology | Year: 2010

Concomitant adenocarcinoma and non-Hodgkin's lymphoma, both located in the intestinal tract, are unusual. Collision tumors of the colon on the other hand are extremely rare neoplasms. A case of true collision tumor of a marginal zone lymphoma and a moderately differentiated adenocarcinoma of the ascending colon (hepatic flexure) is reported. Simultaneously, a third primary is identified as follicular lymphoma involving the terminal ileum. Correlation with clinical history, radiology investigations, endoscopic findings and histological examination of the resected specimen as well as the use of ancillary techniques such as immunohistochemistry are the most useful in making the correct diagnosis of a synchronous three primaries involving the small bowel and colon. Therefore, we present these three primary synchronous neoplasms involving two different parts of the gastrointestinal tract, with two of these three primaries colliding at one organ.


We report a case of upper gastrointestinal bleeding caused by a gastrointestinal stromal tumor in a 50-year old man. The patient was having melena for two months, and on admission he was hemodynamically stable. Upper G.I endoscopy showed diffuse gastritis and an extrinsic compressing mass in the upper part of the stomach. CT scan of the abdomen showed exophytic mass in the fundus of the stomach, with central necrosis. The patient was submitted to operative management. There were no features of dissemination but there was invasion of the hilum of the spleen. Wide local resection and splenectomy performed. Post operative course was complicated by a bleeding from the anastomotic site that required re-exploration and suturing of the bleeding vessel. Histologic examination revealed that it was composed of spindle-shaped cells with elongated nuclei. Post operatively the patient received adjuvant treatment with Imatinib [Gleevec]. The patient has an uneventful follow-up period so far.


Bastaki J.M.,Sabah Hospital
Ear, Nose and Throat Journal | Year: 2015

Tonsillitis and pharyngitis are among the most common infections in the head and neck. Viral tonsillitis is usually caused by enterovirus, influenza, parainfluenza, adenovirus, rhinovirus and Epstein-Barr virus (causing infectious mononucleosis). Acute bacterial tonsillitis is most commonly caused by group A beta-hemolytic streptococci. On the other hand, pseudomembranous and necrotizing tonsillitis are usually caused by fusiform bacilli and spirochetes. Here we report what is, to our knowledge, the first case of necrotizing tonsillitis caused by group C beta-hemolytic streptococci. © 2015 Vendome Group.


Abdul-Rasoul M.,Mubarak Alkabeer Hospital | Al-Mahdi M.,Adan Hospital | Al-Qattan H.,Adan Hospital | Al-Tarkait N.,Sabah Hospital | And 4 more authors.
Pediatric Diabetes | Year: 2010

Background: Diabetic ketoacidosis (DKA) has significant morbidity and mortality, and is common at diagnosis in children. Objective: Describe the frequency and severity of DKA at diagnosis of type 1 diabetes mellitus (T1DM) in children in Kuwait. Methods: Hospital records of 677 diabetic children less than 12 yr of age, diagnosed during the period of 2000-2006 were reviewed. DKA was defined as blood glucose > 11 mmol/L, pH < 7.3, and/or bicarbonate < 15 mmol/L with ketonuria. Results: Of all patients diagnosed with T1DM, 255 (37.7%) presented with DKA. The frequency of DKA was constant between 2000 and 2002 (42.7-41.5%), but decreased in the following years to 30.7% in 2006 (p < 0.005). The majority had either mild or moderate DKA (74.1%). Fifty-one (36.7%) of all children in the 0-4 yr had severe DKA compared to ten (2.9%) in the 5- to 8-yr-old group, and three (1.5%) in 9- to 12-yr-old patients (p < 0.0001). Moreover, 83% of children with severe DKA were in the 0-4 yr age group. One child (0.15%) died and twenty-seven (4%) needed intensive care unit (ICU) care. Conclusion: Our study provides recent data on Middle Eastern population, for whom data are sparse. Although it has significantly decreased, the frequency of DKA at presentation of T1DM in children in Kuwait is still high, secondary to the high prevalence of diabetes in the community. Young children, especially those less than 2 yr old remain at high risk. Increasing the general awareness of the public as well as of pediatricians to the disease may lead to early diagnosis before the development of acidosis. © 2009 John Wiley & Sons A/S.


Alfadhli S.,Kuwait University | Almutawa Q.,Kuwait University | Abbas J.M.K.,Sabah Hospital | Doi S.A.R.,University of Queensland | Doi S.A.R.,Princess Alexandra Hospital
Endocrine | Year: 2013

Analysing two CTLA-4 markers [exon 1 A49G single nucleotide polymorphism (SNP) and exon 4 3′UTR (AT)n repeat] and the ICOS intron 4 (GT)n marker for their potential association with HT, and exploring the effect of the tested SNPs on the CTLA-4 isoform expression at the mRNA and protein levels. Total of 270 age-gender-ethnically matched subjects were genotyped by fluorescent-labelled restriction fragment length polymorphism, multiplex PCR, and fragment analysis. Sequencing was used to confirm the genotyping results. Expression of the full-length and soluble CTLA-4 mRNAs analysed using real-time PCR. Sera from subjects were screened for sCTLA-4 using ELISA. Tested subjects revealed ten alleles and sixteen genotypes of CTLA-4 3′UTR(AT)n. The 3′UTR(AT)n was significantly associated with HT: allele (AT)15 and genotype 15/15 were found to cause susceptibility to HT (P = 0.004, OR = 2.13, 95 % CI = 1.26-3.58 and P = 0.029, OR = 2.77, 95 % CI = 1.1-6.94, respectively), whereas allele (AT)6 and genotype 6/6 were found to be protective of HT (P = 0.00002, OR = 0.36, 95 % CI = 0.227-0.57 and P = 0.001, OR = 0.357, 95 % CI = 0.1980.64, respectively). SNP A49G and ICOS(GT)n revealed no significant association with HT (P > 0.05). The expression of sCTLA-4 was inversely proportional to the number of 3′UTR(AT)n repeats, with heterozygous and longer (AT)n repeats showing lower levels of sCTLA-4 mRNA than those with shorter alleles in HC and HT (P = 0.001 and P = 0.04, respectively). Significant increase in the serum level of sCTLA-4 was observed in HT patients compared with the HC (P = 0.0007). The novel finding in our study is that the CTLA-4 3′UTR(AT)n proven to be a key player in the pathogenesis of HT. © 2012 Springer Science+Business Media New York.


PubMed | Kuwait University and Sabah Hospital
Type: Journal Article | Journal: Gene | Year: 2016

The purpose of our study was to identify the currently lacking molecular mechanism that accounts for the co-occurrence of two seemingly disparate diseases: psoriasis and type II diabetes. We aimed to investigate a panel of 84 genes related to the diabetic regulatory network in psoriasis (Ps), psoriasis type II diabetes (Ps-T2D), type II diabetes (T2D) and healthy control (HC). We hypothesize that such attempts would provide novel diagnostic markers and/or insights into pathogenesis of the disease. A quantitative Real Time-PCR Human Diabetes RT(2) Profiler PCR Array was chosen to explore the expression profile 84 diabetic genes in study subjects. Statistical analysis was carried out using appropriate software. The analysis revealed three candidate genes GSK3B, PTPN1, STX4 that are differentially expressed in study subjects. GSK3B was highly significant in Ps-T2D (P=0.00018, FR=-26.6), followed by Ps (P=0.0028, FR=-14.5) and T2D groups (P=0.032, FR=-5.9). PTPN1 showed significant association only with PS-T2D (P=0.00027, FR=-8.5). STX4 showed significant association with both Ps (P=0.0002, FR=-20) and Ps-T2D (P=0.0016, FR=-11.2). ACE represents an additional marker that showed suggestive association with Ps (P=0.0079, FR=-9.37). Our study highlights the complex genetics of Ps-T2D and present biomarkers for the development of T2D in Ps cases.

Loading Sabah Hospital collaborators
Loading Sabah Hospital collaborators